About
Biologics, Small Molecules
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalBoston & New England
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
4
As Collaborator
3
Total Enrollment
2,938
By Phase
PHASE3: 2PHASE2: 3NA: 1
By Status
UNKNOWN: 3COMPLETED: 2RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT03059173Collaborator
Interest of Myo-inositol Supplementation in Women With Polycystic Ovarian Syndrome
PHASE3Recruiting
276 participants
Started: Sep 12, 2023 · Completed: Dec 31, 2027
NCT04853069Collaborator
Oestrogen Treatment for COVID-19 Symptoms
PHASE2Unknown
2,000 participants
Started: May 17, 2021 · Completed: Mar 31, 2022
NCT04348864Collaborator
COVID-19 Diagnostic Self-testing Using Virtual Point-of-care
NAUnknown
200 participants
Started: Apr 16, 2020 · Completed: Apr 30, 2022
NCT05288907Lead Sponsor
SOOTHER Trial to Treat Rectal Itch
N/ACompleted
20 participants
Started: Sep 1, 2018 · Completed: Dec 10, 2021
NCT03317028Lead Sponsor
CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)
PHASE2Completed
201 participants
Started: Oct 10, 2017 · Completed: Apr 21, 2020
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...